AMP Kinase as a New Hope for Tackling Long-Term COVID-19 Complications

Medical News: Researchers from various esteemed institutions, including Nursing and Medical Science Riyadh ELM University in Saudi Arabia, Guru Nanak Institute of Pharmacy in India, Lalit Narayan Mithila University-India, The Glocal University in Saharanpur-India, UMM Matrix Innovations Private Limited-India, and the University of Ha'il, Saudi Arabia, have delved into a promising solution for long-term post-COVID-19 complications: the enzyme AMPK. Known formally as adenosine monophosphate-activated protein kinase, AMPK is drawing attention for its potential in alleviating lingering health issues related to COVID-19, particularly those linked to glucose metabolism and inflammation.


Graphical Abstract: AMP Kinase as a New Hope for Tackling Long-Term COVID-19 Complications

COVID-19, caused by the SARS-CoV-2 virus, has left many patients facing ongoing health issues, especially those related to the body’s metabolic functions. For both diabetics and non-diabetics, COVID-19 has highlighted the need for new approaches to manage these complications. This Medical News report focuses on how AMPK, a key player in energy regulation and glucose metabolism, could become a powerful target for therapeutic development against post-COVID-19 issues.
 
The Importance of AMPK in Health and COVID-19 Recovery
AMPK is a crucial enzyme that acts as a “cellular energy sensor,” regulating how cells produce and use energy. In simpler terms, it helps cells balance their energy levels by increasing the use of fats and sugars when the body’s energy is low. When activated, AMPK can impact various processes, such as enhancing glucose uptake and reducing inflammation, two critical factors for people suffering from long-term COVID-19 effects.
 
SARS-CoV-2 infection, however, disrupts AMPK activity, throwing off the balance of these processes, which leads to metabolic problems. By boosting AMPK activity, researchers believe it’s possible to help the body regain balance and improve health outcomes for people facing persistent post-COVID-19 symptoms.
 
How AMPK Could Help Post-COVID-19 Patients
Several natural compounds have been identified as potential AMPK activators. Research has shown that compounds such as capsaicinoids (from chili peppers), curcumin (from turmeric), phytoestrogens (from plants like soy), cilostazol (a medication for blood flow), and momordicosides (from bitter melon) could help boost AMPK levels in the body. These compounds have been found to enhance fatty acid breakdown and improve insulin sensitivity, which are critical for maintaining healthy glucose levels.
 
Metformin, a commonly used medication for type 2 diabetes, also stimulates AMPK. Notably, its effects on glucose metabolism and insulin sensitivity seem to counteract the metabolic disruptions caused by COVID-19. Observational studies and clinical trials, such as the COVID-OUT and TOGETHER trials, have shown that metformin use during COVID-19 is associated with a reduced risk of severe complications. These findings underscore metformin’s pot ential as a supportive treatment for managing metabolic complications following COVID-19.
 
Why AMPK Matters for Diabetes and COVID-19
For diabetic patients, COVID-19 poses an extra risk due to the interaction between glucose metabolism and immune function. High blood sugar can weaken immune defenses, making it harder for the body to fight infections like COVID-19. Additionally, inflammation from elevated glucose levels can worsen respiratory issues. For those already diagnosed with diabetes, COVID-19 has led to worsened insulin resistance and glucose metabolism, putting them at higher risk of severe outcomes.
 
AMPK activation has shown promise in managing glucose levels and reducing inflammation. By improving how cells respond to insulin, AMPK could help patients maintain stable blood sugar levels, which is crucial for preventing severe complications in both diabetics and non-diabetics recovering from COVID-19. This enzyme’s potential for managing the body’s energy balance and fighting inflammation makes it a valuable target for addressing the metabolic issues seen in long COVID.
 
AMPK’s Potential Beyond Glucose Metabolism
AMPK isn’t just essential for glucose regulation. It’s also involved in broader cellular functions, including those linked to viral infections. By maintaining energy balance in cells, AMPK could help prevent some of the cellular disruptions caused by SARS-CoV-2. This broad role suggests that activating AMPK might support immune resilience and overall cellular health.
 
Importantly, AMPK is widely distributed in tissues throughout the body, meaning its activation could have systemic benefits. This broad distribution allows it to affect multiple organs, including the liver, muscles, and heart. For COVID-19 survivors experiencing complications across different organs, AMPK activation offers a way to potentially address the widespread impacts of the virus on cellular health.
 
Potential Risks and Challenges
While the therapeutic benefits of AMPK activation are promising, there are potential risks. Over-activation or improper regulation of AMPK can cause side effects due to its involvement in many essential cellular processes. For instance, AMPK plays a role in heart function, so unintended effects on heart cells are a concern. As researchers continue exploring AMPK activators, safety will remain a priority.
 
The wide-reaching effects of AMPK mean that future treatments will need to be carefully designed to activate this enzyme in a controlled manner, targeting the areas most affected by post-COVID-19 complications.
 
Conclusion: A New Path for Post-COVID-19 Treatment
AMPK presents an exciting potential for addressing the complex and varied complications that many COVID-19 survivors face. As an energy regulator, it influences essential processes like glucose metabolism, inflammation, and immune response. By activating AMPK, we may be able to counteract some of the virus’s harmful effects on cellular health, offering patients a path to recovery and improved quality of life.
 
For many COVID-19 survivors, lingering health issues have impacted their daily lives and overall well-being. AMPK activation could provide a targeted, natural way to restore balance in the body’s systems, helping those affected return to a sense of normalcy. The discovery of AMPK as a possible therapeutic target offers a beacon of hope in the search for long-term solutions to post-COVID-19 complications, and future research may unlock new ways to improve outcomes for patients.
 
The study findings were published in the peer-reviewed journal: Life Sciences.
https://www.sciencedirect.com/science/article/abs/pii/S0024320524007926
 
For the latest COVID-19 News, keep on logging to Thailand Medical News.
 
Read Also:
https://www.thailandmedical.news/news/targeting-the-kinase-protein-p70s6k-may-aid-in-the-fight-against-covid-19
 
https://www.thailandmedical.news/news/covid-19-news-study-finds-that-doublecortin-like-kinase-1-dclk1,-a-protein-associated-with-cancer-stem-cells,-plays-a-role-in-sars-cov-2-pathogenesis
 
https://www.thailandmedical.news/news/covid-19-news-p21-activated-kinase-1-pak1-mediated-cytoskeleton-rearrangement-facilitates-sars-cov-2-entry-and-ace2-autophagic-degradation